Elicio TherapeuticsELTX

13F holders, Q4 2025 (December 31)
37holders +9
13new positions
4sold out
2famous investors
$7.96avg. 13F price*

At the end of Q4 2025, 37 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, up 9 from Q3 2025. 13 opened new positions and 4 sold out. The largest holders were Knoll Capital Management, LLC ($5.0M), Vanguard Group Inc. ($4.0M) and Balyasny Asset Management L.P. ($1.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).

Company
Elicio Therapeutics Inc.
CUSIP
28657F103
Latest filing quarter
Q2 2026

History

Number of 13F holders

01020304050 Q1 2024: 18Q1 2024Q2 2024: 20Q2 2024Q3 2024: 18Q3 2024Q4 2024: 17Q4 2024Q1 2025: 24Q1 2025Q2 2025: 21Q2 2025Q3 2025: 28Q3 2025Q4 2025: 37Q4 2025Q1 2026: 47Q1 2026Q2 2026: 48Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions13$1.5M
Exits4$662K

All 13F filers, Q3 2025 → Q4 2025: 318,303 shares bought and 149,804 shares sold, net +168,499 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 37 holders

Knoll Capital Management, LLC 2.30% No change 630,915 $5.0M
Vanguard Group Inc. 0.00% Add +4.9% 496,901 $4.0M
Balyasny Asset Management L.P. 0.00% Reduce -6.3% 138,762 $1.1M
Geode Capital Management, LLC 0.00% Add +2.2% 132,518 $1.1M
Marshall Wace, LLP 0.00% Add +35.4% 117,200 $933K
Susquehanna International Group, LLP 0.00% Reduce -46.7% 64,052 $510K
683 Capital Management, LLC 0.04% New 56,442 $449K
Northern Trust Corp. 0.00% Reduce -1.5% 52,769 $420K
State Street Corp. 0.00% Add +20.9% 46,300 $369K
BlackRock, Inc. 0.00% Add +2.2% 45,179 $360K
UBS Group AG 0.00% Add +356.1% 32,016 $255K
Renaissance Technologies 0.00% Reduce -42.2% 28,111 $224K
CM Management, LLC 0.17% Add +316.7% 25,000 $199K
OMERS ADMINISTRATION Corp 0.00% New 23,500 $187K
Qube Research & Technologies Ltd 0.00% New 20,216 $161K
Quadrature Capital Ltd 0.00% New 17,159 $137K
Squarepoint Ops LLC 0.00% New 16,662 $133K
Occudo Quantitative Strategies LP 0.01% New 15,827 $126K
Morgan Stanley 0.00% Add +847.5% 14,553 $116K
Meyer Handelman Co. 0.00% No change 13,899 $111K
Jefferies Financial Group Inc. 0.00% Add +129.7% 11,942 $95K
Point72 Asset Management 0.00% New 11,652 $93K
HighTower Advisors, LLC 0.00% New 11,186 $89K
Summit Financial, LLC 0.00% New 10,010 $80K
Mayflower Financial Advisors, LLC 0.01% No change 10,000 $80K
Moody LYNN Lieberson & Walker, LLC 0.00% No change 10,000 $80K
&partners 0.00% No change 10,000 $80K
CIBC Private Wealth Group LLC 0.00% No change 7,000 $56K
BNP Paribas Financial Markets 0.00% New 5,668 $45K
Steward Partners Investment Advisory, LLC 0.00% No change 1,554 $12K
Bank of America Corp. 0.00% Reduce -67.7% 1,157 $9K
Farther Finance Advisors, LLC 0.00% Add +10.2% 705 $6K
Group One Trading LLC 0.00% New 323 $3K
Royal Bank of Canada 0.00% New 219 $2K
Wells Fargo & Company 0.00% No change 200 $2K
Fortitude Family Office, LLC 0.00% New 93 $740
SBI Securities Co., Ltd. 0.00% No change 82 $653

"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.